Researchers at the UAB have determined the structure of amyloid fibers formed by the protein hnRNPDL-2, implicated in limb-girdle muscular dystrophy type 3, using high-resolution cryo-electron microscopy (cryo-EM). They have concluded that the inability of the protein to form amyloid fibers, and not aggregation, would be the cause of the disease. This is the first amyloid structure determined at high resolution by a Spanish research team.
The study, published in Nature Communications, informs the search for molecules that stabilize or facilitate amyloid formation and opens the door to the study of other functional amyloids and their mutations using the same technique, in order to better understand their implications in health and disease.
Limb-girdle muscular dystrophy type 3 (LGMD D3) is a rare disease causing progressive muscle weakness caused by point mutations in the hnRNPDL-2 protein. A member of the RNA-associated ribonucleoprotein (RNP) family, it is a little-known protein with the ability to assemble to form functional amyloid structures. Amyloids are formed by the joining of thousands of pieces of the same protein to form very stable and structured fibers (protein aggregates). Their formation is often associated with diseases such as Parkinson's and Alzheimer's, but they are also used by different organisms for functional purposes, although the number of functional amyloids described in humans is still small.
Researchers at the Universitat Autònoma de Barcelona (UAB) have determined that the architecture and activity of the amyloid fibers suggest that they are stable, non-toxic amyloid fibers that bind nucleic acids in their aggregated state. The results indicate that LGMD D3 could be a protein loss-of-function disease: the inability to form the amyloid structures described in the study would cause the pathology.
"Our study challenges the hypothesis that the aggregation of this protein is the cause of the disease and proposes that it is the inability to form a fibrillar structure that has been selected by evolution to bind nucleic acids that causes the pathology," says Salvador Ventura, professor of Biochemistry and Molecular Biology and researcher at the Institute of Biotechnology and Biomedicine (IBB-UAB), who led the research together with the first author of the paper, Javier Garcia-Pardo, a Juan de la Cierva-Incorporación researcher at IBB-UAB.
Researchers have determined the structure of the amyloid fibers of the hnRNPDL-2 protein using high-resolution cryo-electron microscopy (cryo-EM). This is the first structure of a human functional amyloid formed by the complete protein to be solved using this technique—previously, only structures formed by fragments of these proteins had been solved. It is also the first amyloid structure determined at high-resolution by a Spanish research team.
The structure of the protein differs from that of other pathological amyloid proteins in that it has a highly hydrophilic nucleus, which includes the amino acid associated with LGMD D3. In this case, unlike in other diseases, amyloid formation is not toxic, but necessary for the function of the protein.
The results change the concept of the origin of the disease and how it should be treated, say the researchers. "Previously, we thought that, as in many neurodegenerative diseases, LGMD D3 originated because mutations in patients caused the initially soluble protein to form aggregates and, therefore, the search for anti-aggregant molecules could be a potential therapy. Now we know that this would be a mistake, since it is the incorrect formation of the fiber that seems to trigger the disease; therefore, molecules that stabilize this structure or facilitate its formation would be the most appropriate," says Salvador Ventura.
Certain human amyloids can undergo both functional and pathological aggregation, and it is therefore necessary to understand their molecular structures in order to determine their distinctive qualities and functions. For example, RNPs similar to the one studied in this research, such as hnRNPA1 or FUS, are able to form functional amyloid fibers in response to cellular stress, but they can also harbor mutations responsible for disease. These proteins are characterized by a modular architecture, including one or more nucleic acid binding domains, together with disordered regions that are responsible for the formation of their assembly into functional or pathological amyloid structures.
"In recent years, the structures of various amyloid fibers formed by fragments of RNPs have been solved. However, these assemblies may not necessarily coincide with those adopted in the context of complete proteins, as is the case of the structure obtained for hnRNPDL-2 solved in our group," explains Salvador Ventura. "In fact, our structure differs significantly from previous ones and questions some of the assumptions that were considered valid regarding the regulation of these proteins in cells," he points out.
To resolve the structure of hnRNPDL-2 in its assembled state, the research team used the cryo-EM technique, applying special techniques to resolve amyloid structures.
In the past two years, a significant number of amyloid fiber structures have been solved with this technique, but these mainly correspond to pathological amyloids involved in systemic and neurodegenerative diseases.
"Our discovery highlights the power of cryo-EM to study the function of RNPs and the reasons for their link to disease. These proteins have been little studied until now, but they are associated with diseases such as Alzheimer's, muscular dystrophies, cancer, and neurodevelopmental and neuropsychiatric disorders. Thus, our objective now is to take advantage of the experience acquired with this technique to determine the fibrillary states of other functional amyloids and study the effect of mutations, in order to better understand their implications in health and disease," says Salvador Ventura.
The development of this new technology at the UAB will allow researchers to exploit the recently installed cryo-EM platform at the Alba synchrotron, of which the university is a partner. Solving this type of structure requires a great deal of computational power. The IBB's Protein Folding and Conformational Diseases research group led by Salvador Ventura has just acquired a high-powered computer to carry out these calculations.
More information: Javier Garcia-Pardo et al, Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3, Nature Communications (2023). DOI: 10.1038/s41467-023-35854-0
Citation: Structure of amyloid protein offers clues to rare disease cause (2023, February 3) retrieved 3 February 2023 from https://phys.org/news/2023-02-amyloid-protein-clues-rare-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.